Christopher K. Mirabelli has witnessed considerable fluctuations in his stock holdings in Leap Therapeutics. Since 2019, his holdings peaked at around $9.74 million in June 2020, highlighting his substantial stake in the firm. Over the years, he has made several...
Christopher K. Mirabelli has witnessed considerable fluctuations in his stock holdings in Leap Therapeutics. Since 2019, his holdings peaked at around $9.74 million in June 2020, highlighting his substantial stake in the firm. Over the years, he has made several transactions, often selling large amounts of stock, with the highest recorded value around $10.90 million in February 2021. In more recent months, his wealth reflected a decrease, reaching about $678.74k in September 2023, marking a significant decline from past highs. The volatility in his portfolio mirrors the ups and downs of Leap Therapeutics in a challenging market, indicating a strategic approach to his investments aligned with his leadership position in the company. His holdings emphasize not just his commitment to the company's future but also the risks inherent in the biotech sector.